Accolade IPO
Accolade operates a personalized healthcare platform that provides advocacy and navigation services to employees and their families. The company helps people navigate complex healthcare systems through technology and human support, making it attractive to investors focused on the growing healthcare technology sector.
What We Know
Accolade went public in July 2020, trading on NASDAQ under the ticker symbol ACCD. The company priced its IPO at $22 per share, raising approximately $220 million. The stock saw significant volatility in its early trading periods, reflecting broader market sentiment around healthcare technology companies. Since going public, Accolade has continued to expand its platform capabilities and customer base. The company serves employers, health plans, and consumers with personalized healthcare guidance and advocacy services, positioning itself in the growing digital health market.
Frequently Asked Questions
Has Accolade had an IPO?
Yes, Accolade completed its IPO in July 2020. The company went public on NASDAQ under the ticker symbol ACCD.
When is the Accolade IPO date?
Accolade's IPO date was July 2, 2020. The company is already publicly traded, so there is no upcoming IPO date.
How can I buy Accolade stock?
You can buy Accolade stock through any brokerage account since it trades publicly on NASDAQ under the ticker ACCD. The stock is available through major brokers like Fidelity, Charles Schwab, E*TRADE, and others.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts